MOTS-C is preferred for mitochondrial and metabolic research
Measuring biomarkers like fasting insulin, C-peptide, and inflammatory markers (hsCRP) can provide context for whether your metabolic profile aligns with conditions where prescription GLP-1 therapy has the strongest clinical evidence
A prospective cohort study involving 100000 subjects found that the risk of breast cancer increased by 25% (HR=1.25, 95% CI 1.06-1.47) and the risk of prostate cancer increased by 31% (HR=1.31, 95% CI 1.09-1.57) in the highest quintile of IGF-1
Fatty pancreas is independently associated with subsequent diabetes mellitus development: a 10-year prospective cohort study
IV formulations can be administered for a variety of reasons including hydration, liver detoxification, lower blood sugar, antioxidants, cancer nutrition support, weight loss, muscle spasms, asthma etc Is IV Therapy safe